Mednet Logo
HomeHematologyQuestion

What is your preferred chemotherapy regimen for a fit younger patient with mantle cell lymphoma?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Rutgers Cancer Institute of New Jersey

For a young fit patient with mantle cell lymphoma not suitable for observation and in need of treatment, without contraindications to intensive therapy, my preferred approach is to use the MCL Younger strategy of alternating RCHOP and cytarabine-based therapy as induction. I will routinely substitut...

Register or Sign In to see full answer